#BGBl. 2026 I Nr. 149Twenty-Fourth Regulation Amending the Medicinal Products Prescription Regulation
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
This regulation amends Germany’s rules on which medicinal products require a prescription. The text provided only contains publication metadata and does not include the detailed amendment, so the specific substances or prescription-status changes cannot be identified from this excerpt.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Amends Germany’s Medicinal Products Prescription Regulation
- Concerns prescription requirements for medicinal products
- Specific affected substances or medicines are not available in the provided text
Affected Parties
pharmaceutical companiespharmacies+2 more…
Tags
pharmaceuticals,prescription medicines,health regulation